Vasopressin Receptor Mutations in Nephrogenic Diabetes Insipidus

Seminars in Nephrology

Volumn 28, Issue 3, 2008, Pages 245-251

  Bichet, Daniel G ^a  

^a Groupe d'Étude des Protéines Membranaires   (Canada)

Author keywords

AVPR2 mutations; misfolded mutants; mutational analysis; Nephrogenic diabetes insipidus; pharmacological chaperones

Indexed keywords

AQUAPORIN 2; ARGIPRESSIN RECEPTOR; CHAPERONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ARTICLE; CELL MEMBRANE; CHRONIC KIDNEY FAILURE; CYSTIC FIBROSIS; DEHYDRATION; ENDOPLASMIC RETICULUM; FABRY DISEASE; GENETIC DISORDER; HUMAN; KIDNEY COLLECTING TUBULE; MENTAL DEFICIENCY; MISSENSE MUTATION; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN FOLDING; RNA INTERFERENCE; X CHROMOSOME LINKED DISORDER;

CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; MUTATION; RECEPTORS, VASOPRESSIN;

EID: 44449086408     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2008.03.005     Document Type: Article

References (30)

1. Fredriksson R., Lagerstrom M.C., Lundin L.G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63 (2003) 1256-1272
2. Perez D.M. The evolutionarily triumphant G-protein-coupled receptor. Mol Pharmacol 63 (2003) 1202-1205
3. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
4. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
5. Rosenbaum D.M., Cherezov V., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 318 (2007) 1266-1273
6. Nielsen S., Frokiaer J., Marples D., Kwon T.H., Agre P., and Knepper M.A. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82 (2002) 205-244
7. Tasken K., and Aandahl E.M. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84 (2004) 137-167
8. McConnachie G., Langeberg L.K., and Scott J.D. AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med 12 (2006) 317-323
9. Zaccolo M., and Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295 (2002) 1711-1715
10. Henn V., Edemir B., Stefan E., Wiesner B., Lorenz D., Theilig F., et al. Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells. J Biol Chem 279 (2004) 26654-26665
11. Chen L., Marquardt M.L., Tester D.J., Sampson K.J., Ackerman M.J., and Kass R.S. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A 104 (2007) 20990-20995
12. Yang B., Bankir L., Gillespie A., Epstein C.J., and Verkman A.S. Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B. J Biol Chem 277 (2002) 10633-10637
13. Yang B., and Bankir L. Urea and urine concentrating ability: new insights from studies in mice. Am J Physiol Renal Physiol 288 (2005) F881-F896
14. Bankir L., Fernandes S., Bardoux P., Bouby N., and Bichet D.G. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16 (2005) 1920-1928
15. Snyder P.M. Minireview: regulation of epithelial Na+ channel trafficking. Endocrinology 146 (2005) 5079-5085
16. Fujiwara T.M., and Bichet D.G. Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol 16 (2005) 2836-2846
17. Arthus M.F., Lonergan M., Crumley M.J., Naumova A.K., Morin D., De Marco L.A., et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 11 (2000) 1044-1054
18. Morello J.P., Salahpour A., Laperrière A., Bernier V., Arthus M.-F., Lonergan M., et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105 (2000) 887-895
19. Conn P.M., Ulloa-Aguirre A., Ito J., and Janovick J.A. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev 59 (2007) 225-250
20. Romisch K. A cure for traffic jams: small molecule chaperones in the endoplasmic reticulum. Traffic 5 (2004) 815-820
21. Cravatt B.F., Simon G.M., and Yates III J.R. The biological impact of mass-spectrometry-based proteomics. Nature 450 (2007) 991-1000
22. Wang X., Venable J., LaPointe P., Hutt D.M., Koulov A.V., Coppinger J., et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127 (2006) 803-815
23. Cohen F.E., and Kelly J.W. Therapeutic approaches to protein-misfolding diseases. Nature 426 (2003) 905-909
24. Bernier V., Morello J.P., Zarruk A., Debrand N., Salahpour A., Lonergan M., et al. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 17 (2006) 232-243
25. Bernier V., Lagace M., Lonergan M., Arthus M.F., Bichet D.G., and Bouvier M. Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Mol Endocrinol 18 (2004) 2074-2084
26. Ulinski T., Grapin C., Forin V., Vargas-Poussou R., Deschenes G., and Bensman A. Severe bladder dysfunction in a family with ADH receptor gene mutation responsible for X-linked nephrogenic diabetes insipidus. Nephrol Dial Transplant 19 (2004) 2928-2929
27. Shalev H., Romanovsky I., Knoers N.V., Lupa S., and Landau D. Bladder function impairment in aquaporin-2 defective nephrogenic diabetes insipidus. Nephrol Dial Transplant 19 (2004) 608-613
28. Yang B., Zhao D., Qian L., and Verkman A.S. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion. Am J Physiol Renal Physiol 291 (2006) F465-F472
29. Tesmer J.J., Sunahara R.K., Gilman A.G., and Sprang S.R. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. Science 278 (1997) 1907-1916
30. Mouillac B., Chini B., Balestre M.N., Elands J., Trumpp-Kallmeyer S., Hoflack J., et al. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J Biol Chem 270 (1995) 25771-25777